Top Tweets for #bsAB
Here's a short report of worship at Bellshill SA today:
https://t.co/zX0179f7C6
#BSAB #Cardiff #SuchLove #TheLordIsGracious #GodsHeartForThePoor
Earlier today on our Facebook page we shared 'Don't Doubt Him Now', played by Alex Ramsay and Yvonne Ferguson: https://t.co/ekx3z5pEIf
#BSAB #DontDoubtHimNow #AlexRamsay #YvonneFerguson
https://t.co/93PMKGAvCJ
Thank you @OncBrothers for discussing practical aspects of myeloma care!! Beyond honored to be in the same room to discuss
#BSAB #CART #cereblon and #RRMM with long-time colleagues @Rfonsi1 @VincentRK
#IMWG26 inaugural Brian Durie Awardee @NoopurRajeMD speak on critical question #CART or #BsAb T cell engagers in 1st relapse #mmsm @IMFmyeloma @VincentRK
Grateful for Grant Approval to Investigate Gender-Based Disparities in Cellular Therapy Outcomes - @BilalAbidMD
https://t.co/EgAQbCLH6U
@kansagraMD @BloodCancerJnl Thank you so much for highlighting this paper!! Too few patients have access to #bsab -especially talquetamab-which can be scary for pts due to side effects. Any evidence to increase access in special populations, to me, is relevant! @HossamAli_MD @FaizAnwerMD1 @LouisWilliamsMD
Afternoon poster session kick off now #AACR26! Find out #mmsm cell plasticity & senescence as a mechanism of resistance to #BsAb & #CART by undergraduate superstar Sofia Arbelaez @Yale https://t.co/Vjn1q8FpPg & @christoscha @MegVoda https://t.co/b1fXWBU2BV @MayoCancerCare
@gloria_iacoboni: Survival after CD20/CD3-targeted bispecific antibody therapy in patients
with relapsed/refractory follicular lymphoma according to bendamustine
exposure. #hematology #follicular #lymphoma #lymsm #BsAb
Great poster to highlight cardiac AEs and risk factors with #BSAB! @ClevelandClinic @clevelandclinicmd @LouisWilliamsMD @FaizAnwerMD1
#ASH25 Come swing by our poster #4066. We show the incidence, risk factor and outcome of CV events during teclistamab in a multicenter registry! #USMMITC @MoffittNews @PennCardiology @PennCancer @md_addison @RahulBanerjeeMD @thisisJamesD amongst many others!
We asked AI models to rank the most anticipated bispecific antibody (BsAb) trials ahead of @myESMO 2025 — and here’s their consensus.
Top-ranked: DeLLphi-303
Focus areas: SCLC and NSCLC BsAb innovation, novel ADC–IO combinations, and pan-tumor expansion.
Which #BsAb trial are you following at #ESMO2025?
Explore more insights and data from #ESMO25: https://t.co/cm6D8IcxgK
#LARVOL #CancerResearch #CancerData #Oncology #OncologyInsights #Gynecology #MedicalOncology #BsAbs | @StephenVLiu | @SuyogCancer | @HHorinouchi | @DrKatyMoore | @DavidSherMD | @ArndtVogel
Join @AjayNookaMD and me to share experiences on outpatient practice for #CART #BsAb in #mmsm at noon today, RM714B, #IMS2025: practical management tips, infrastructure considerations, and a peek into roles for remote monitoring, telehealth, AI and ML @MayoCancerCare
It’s always a pleasure to catch up with @YiLinMDPhD! Today she shared insights into outpatient administration of bispecifics and immunotherapy, and absolute lymphocyte count as a biomarker for monitoring safety after cilta-cel.
#MMSM #IMS25 @Myeloma_Society
Here's this week's #BSAB #WednesdayDevotions which Michelle Addie shared at band practice last week #ThoughtFromTheBand #BandPracticeDevotions #BandDevotions
https://t.co/oNeZBuK7KX
Dr. Danai Dima on RedirecTT-1 (talquetamab + teclistamab) in RRMM: ORR high with median PFS 15.4 mo; 18-mo DOR 86% (82% with EMD). Infections frequent (any-grade 89%, grade 3–4 64%, grade 5 12%); hypogammaglobulinemia 70%. #MultipleMyeloma #bsAb #DAVAHeme
In case you missed it, our incredible LJ Andrews was at @comic_con for the first time! We are all so proud of her! 🤩🥹
#comiccon #comicconauthors #bsab #theeverking #thebrokenkingdoms
#ljandrews
Thrilled to share our latest publication in @IJMS_MDPI on Bispecific Antibodies in Solid Tumors: Advances and Challenges! A deep dive into the promise & hurdles of this emerging therapy. @MCIStrong @mhshospital
#Oncology #BsAb #IJMS https://t.co/gTpHYLTXOb
🚀Bispecific Antibodies Cancer Therapy 2025
📺Video Overview📺
📊Blinatumomab (69% MRD negativity in ALL),
🩸Elranatamab (60% myeloma response)
🫁Tarlatamab (25% SCLC).
📰 Article With References: https://t.co/ETsebV8RnK
#BsAb #CancerTherapy #Oncology2025
@DrSamuelBHume
@levin_beltran
@ayirpelle
@srqstockpicker
@Tecnoestres
@_LittleFire1
@anguebus
@bioinvestor24
@kachofugetsujp
@ImmunoLatinXs
@AsAshraf123321
@CeriFielding
@HendryVictoria
@LabRullo
@sandra04850184
@leonardopviana
@kucharz_neuro
@Adrianapordios
@jaypsv
@z_veitch
@ghostbnh
@Znger4
@dgovejero
@chinnamon39
@VaqueraH_md
@VaniaGodo
@CGuindel
@Avocadosssss
@anqigao
@BlackSamrat
@benito_quintero
@prakashdn
@Sabari29_r
@noquiDeConicet
@Mohamed52645745
@AriokLord
@amarabed101
@phonekiki
@Pharma_Mty
@ONNESHA092
@SofyNCVarGar
@DserhsingLai
@K_seataii
@dr_jmvaldes
@samir_barghout
@a_procureur
@whitevictor13
@Africa_Gonz
Most Popular Users
Elon Musk 
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.8M followers
Taylor Swift
@taylorswift13
81.7M followers
Lady Gaga
@ladygaga
73.2M followers
Virat Kohli
@imvkohli
70.2M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
60.9M followers
X
@x
60.8M followers